Cell culture process for glycoproteins

Details for Australian Patent Application No. 2005200622 (hide)

Owner Genentech, Inc.

Inventors Gawlitzek, Martin; Andersen, Dana C; Hoy, Cynthia A; Bridges, Tiffany M

Agent Griffith Hack

Pub. Number AU-B-2005200622

Parent 778046

Filing date 11 February 2005

Wipo publication date 10 March 2005

Acceptance publication date 23 August 2007

International Classifications

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/72 (2006.01) Enzymes, e.g. ligases (6.) - Urokinase

C12N 15/58 (2006.01) Mutation or genetic engineering

C12P 21/00 (2006.01) Preparation of peptides or proteins

C12R 1/91 (2006.01)

Event Publications

3 March 2005 Complete Application Filed

10 March 2005 Application Open to Public Inspection

  Published as AU-B-2005200622

23 August 2007 Application Accepted

  Published as AU-B-2005200622

20 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005200623-Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism

2005200621-A novel C. elegans p21-activated kinase (PAK) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of PAK activity in the nematode, Caenorhabditis elegans